In addition to the direct health risks of the COVID-19, the indirect effects have also severely disrupted access to basic health services that prevent, diagnose, and treat patients with noncommunicable diseases. Every year, NCDs kill 41 million people — making up 71% of all deaths globally. The majority of these deaths occur in low- and middle-income countries, where health systems often have limited capacity and resources for health and care.
We’re now facing a syndemic — the convergence of several epidemics — with individuals around the globe facing severe disruption to care, preventive screenings, and postponed surgeries. It has also created a ticking time bomb when it comes to cardiovascular health. At the height of the crisis, more than half of the 155 countries surveyed by the World Health Organization reported partially or completely disrupted services for hypertension treatment, with 31% of cardiovascular emergencies disrupted.
On Wednesday, March 31, Devex will host a virtual event in partnership with the Novartis Foundation to explore how the global health community can build on this momentum of increased use and trust in virtual health and care services, to leverage technology for improving cardiovascular population health, especially in LMICs.
Register now and check out the HealthTech Dialogue Hub. The hub hosts virtual events and showcases lessons and best practices from technology-enabled innovations in health and care. It also facilitates ongoing dialogue between government leaders and other policymakers, health workers, innovators, and researchers.
Welcome & introduction by Catherine Cheney, Devex Senior Reporter
Spotlight - Data driven decision making for heart health —
Fireside chat on the importance of data and AI driven approaches to addressing CVD
-Prof.Fausto Pinto, President of the World Health Federation, World Heart Federation
-Moderator: Amruta Byatnal, Associate Editor, Devex
-Prof. Dr. Edson Amaro Jr, neuroradiologist and Head Big Data Analytics, Albert Einstein Hospital
-Farouk Meralli, Founder and Chief Executive Officer, mClinica
-Dr. Nneka Mobisson, Co-Founder and CEO, mDoc
-Moderator: Catherine Cheney, Senior Reporter, Devex
Closing remarks by Catherine Cheney, Devex Senior Reporter and Jason Shellaby, Novartis Foundation Director of Global Health Policy
Professor. Dr. Edson Amaro Jr is a neuroradiologist and Head Big Data Analytics at Albert Einstein Hospital. He graduated in medicine with a PhD in neuroimaging at University of São Paulo, and finished postdoctoral degree from the Institute of Psychiatry, King's College London. He was responsible for the Albert Einstein Hospital Brain Institute from 2008 to 2012.
Farouk Meralli is the Founder of mClinica Pharmacy Solutions, a healthcare startup connecting pharmacies in emerging markets through a common mobile technology platform. mClinica operates across southeast Asia connecting over 45,000 pharmacies and 190,000 pharmacy professionals which reach over 150 million patients. Previously, Farouk held senior roles in strategy and product development at global pharmaceutical companies Pfizer, Sanofi, and Roche. He is the recipient of the Harvard Alumni Public Health Innovator Award, an Endeavor Entrepreneur, a Board Advisor at PATH, and the Chair and Founder of non profit organization, Borderless World Volunteers. He holds a Bachelors in Biomedical Sciences and International Development Studies from McGill University and a Masters in Health Policy and Management from Harvard University.
Dr. L. Nneka Mobisson is co-Founder and CEO of mDoc, a digital health social enterprise which integrates proven methodologies in quality improvement, data, and behavioral science with technology to provide self-care support to people living with chronic health needs in sub-Saharan Africa. Prior to mDoc, Dr. Mobisson served as Executive Director, Africa, at the Institute for Healthcare Improvement Dr. Mobisson, also served as Vice President of Community Health and Population Health Management at Connecticut Hospital Association and worked on health care strategy at McKinsey & Company. She also worked at the World Bank, and Merck & Co.
Professor Fausto J. Pinto, MD, PhD, is Dean, Faculty of Medicine, University of Lisbon, Portugal; Full Professor of Cardiology and Head of Cardiology and Heart and Vascular Department at University Hospital Sta Maria/CHULN, Lisbon School of Medicine, Portugal; He is also President of World Heart Federation (WHF) (2021-22); President of European Society of Cardiology (ESC 2014-2016); Fellow and Gold Medal of the European Society of Cardiology (FESC), American College of Cardiology (FACC), Society for Cardiac Angiography and Interventions (FSCAI), American Society of Echocardiography (FASE), American Society of Angiology (FASA). He is a full Member of the Portuguese Academy of Medicine and honorary member of Academia Nacional de Medicina do Brasil, Czech Cardiology Society, Colombian Society of Cardiology, Hungarian Society of Cardiology, Japanese Circulation Society, Societé Française de Cardiologie, Societá Italiana di Ecografia Cardiovasculare, Peruvian Society of Cardiology, Romanian Society of Cardiology, Romanian Academy of Medical Sciences, Russian Society of Cardiology, Slovakian Society of Cardiology.
Jason Shellaby is the Director of Global Health Policy at the Novartis Foundation (NF). During his time at NF, Jason has led several global health initiatives, including the national scale-up of a telemedicine program in Ghana and the management and policy integration of urban hypertension programs in Senegal, Ghana and Vietnam. Prior to NF, Jason served as Director of External Affairs at Village Health Works, supporting the scale up and capacity building for health care facilities in Burundi, East Africa and managing the NYC office. He was a Program Fellow at the Clinton Global Initiative, and worked on the Environmental Initiatives team at the World Economic Forum. Jason holds a BA in International Relations from Tufts University, an MA in International Affairs from The Graduate Institute of International and Development Studies, and an MSc in Global Health Policy from the London School of Hygiene and Tropical Medicine.
Amruta Byatnal is an Associate Editor at Devex based in New Delhi. She reports on global health, gender and human rights. Previously, she worked for News Deeply and The Hindu. She is a graduate of Cornell University where she studied international development.
Catherine Cheney is a Senior Reporter for Devex. She covers the West Coast of the U.S., focusing on the role of technology, innovation, and philanthropy in achieving the Sustainable Development Goals. And she frequently represents Devex as a speaker and moderator. Prior to joining Devex, Catherine earned her bachelor’s and master’s degrees from Yale University, worked as a web producer for POLITICO and reporter for World Politics Review, and helped to launch NationSwell. Catherine has reported domestically and internationally for outlets including The Atlantic and the Washington Post. Outside of her own reporting, Catherine also supports other journalists to cover what is working, through her work with the Solutions Journalism Network.